These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31531059)

  • 1. Characterization of Novel Fragment Antibodies Against TNF-alpha Isolated Using Phage Display Technique.
    Alizadeha AA; Hamzeh-Mivehroud M; Haddad E; Haddad N; Sharifi M; Mohammadi S; Pourtaghi-Anvarian S; Dastmalchi S
    Iran J Pharm Res; 2019; 18(2):759-771. PubMed ID: 31531059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the novel anti-TNF-α single-chain fragment antibodies using experimental and computational approaches.
    Pourtaghi-Anvarian S; Mohammadi S; Hamzeh-Mivehroud M; Alizadeh AA; Dastmalchi S
    Prep Biochem Biotechnol; 2019; 49(1):38-47. PubMed ID: 30735094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and Purification of a Novel Anti-TNF-α Single Chain Fragment Variable Antibody.
    Alizadeh AA; Hamzeh-Mivehroud M; Dastmalchi S
    Adv Pharm Bull; 2015 Dec; 5(Suppl 1):667-72. PubMed ID: 26793614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Novel Single Chain Fragment Variable Antibodies Against TNF-α Using Phage Display Technology.
    Alizadeh AA; Hamzeh-Mivehroud M; Dastmalchi S
    Adv Pharm Bull; 2015 Dec; 5(Suppl 1):661-6. PubMed ID: 26793613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of novel peptides against TNF-α using phage display technique and in silico modeling of their modes of binding.
    Alizadeh AA; Hamzeh-Mivehroud M; Farajzadeh M; Dastmalchi S
    Eur J Pharm Sci; 2017 Jan; 96():490-498. PubMed ID: 27720899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Downstream characterization of anti-TNF-α single chain variable fragment antibodies.
    Abdolalizadeh J; Nouri M; Zolbanin JM; Baradaran B; Barzegari A; Omidi Y
    Hum Antibodies; 2012; 21(1-2):41-8. PubMed ID: 22885959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology.
    Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y
    Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation and Characterization of Novel Phage Displayed scFv Fragment for Human Tumor Necrosis Factor Alpha and Molecular Docking Analysis of Their Interactions.
    Safarpour H; Shahmirzaie M; Rezaee E; Barati M; Safarnejad MR; H Shirazi F
    Iran J Pharm Res; 2018; 17(2):743-752. PubMed ID: 29881431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Affinity Purification of Tumor Necrosis Factor-α Expressed in Raji Cells by Produced scFv Antibody Coupled CNBr-Activated Sepharose.
    Abdolalizadeh J; Majidi Zolbanin J; Nouri M; Baradaran B; Movassaghpour A; Farajnia S; Omidi Y
    Adv Pharm Bull; 2013; 3(1):19-23. PubMed ID: 24312807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rat tumour necrosis factor-alpha: expression in recombinant Pichia pastoris, purification, characterization and development of a novel ELISA.
    Rees GS; Gee CK; Ward HL; Ball C; Tarrant GM; Poole S; Bristow AF
    Eur Cytokine Netw; 1999 Sep; 10(3):383-92. PubMed ID: 10477395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and Construction of a Novel Humanized Single-Chain Variable-Fragment Antibody Against the Tumor Necrosis Factor Alpha.
    Farajzadeh D; Karimi-Gharigh S; Jalali-Kondori P; Dastmalchi S
    Iran J Pharm Res; 2019; 18(1):308-319. PubMed ID: 31089365
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant H22(scFv) blocks CD64 and prevents the capture of anti-TNF monoclonal antibody. A potential strategy to enhance anti-TNF therapy.
    Hristodorov D; Mladenov R; Brehm H; Fischer R; Barth S; Thepen T
    MAbs; 2014; 6(5):1283-9. PubMed ID: 25517313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
    Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
    Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Screening of TACE peptide inhibitors from a phage display random 15-peptide library by recombinant TACE ecotodomain].
    Huang W; Li LB; Han L; Zhang H; Yang YZ
    Sheng Wu Gong Cheng Xue Bao; 2005 Jan; 21(1):30-5. PubMed ID: 15859325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of ligand binding by the human p55 tumour-necrosis-factor receptor. Involvement of individual cysteine-rich repeats.
    Corcoran AE; Barrett K; Turner M; Brown A; Kissonerghis AM; Gadnell M; Gray PW; Chernajovsky Y; Feldmann M
    Eur J Biochem; 1994 Aug; 223(3):831-40. PubMed ID: 8055960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Soluble tumor necrosis factor-alpha (TNF-alpha) receptors in human colostrum and milk bind to TNF-alpha and neutralize TNF-alpha bioactivity.
    Buescher ES; McWilliams-Koeppen P
    Pediatr Res; 1998 Jul; 44(1):37-42. PubMed ID: 9667368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cloning and expression of human V-genes derived from phage display libraries as fully assembled human anti-TNF alpha monoclonal antibodies.
    Mahler SM; Marquis CP; Brown G; Roberts A; Hoogenboom HR
    Immunotechnology; 1997 Mar; 3(1):31-43. PubMed ID: 9154466
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A strategy for high-level expression of a single-chain variable fragment against TNFα by subcloning antibody variable regions from the phage display vector pCANTAB 5E into pBV220.
    Yang T; Yang L; Chai W; Li R; Xie J; Niu B
    Protein Expr Purif; 2011 Mar; 76(1):109-14. PubMed ID: 20951213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant expression, purification and bioactivity characterization of extracellular domain of human tumor necrosis factor receptor 1.
    Zhang C; Li A; Wang R; Cao Y; Jiang H; Ouyang S; Ma X; Lu Y
    Protein Expr Purif; 2019 Mar; 155():21-26. PubMed ID: 30414969
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.